ArticlePregnancy (Hoboken, N.J.)2026
Comprehensive blood pressure management to improve early postpartum blood pressure parameters: A randomized controlled trial.
Article in Pregnancy (Hoboken, N.J.), 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 2 papers.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
2 citing papers in PubMed.
- Article
- Two Patients, One Plan: Redesigning Transitions of Care in High-Risk Pregnancy with Mom-Baby Dyadic Models.Missouri medicineArticle
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
12 authors.
Funding
Abstract
Introduction: Adherence to blood pressure (BP) evaluation 7-10 days after pregnancy complicated by hypertension is poor. Current guidelines for postpartum BP control are more liberal than those for nonpregnant individuals. Our objective was to determine whether a comprehensive BP management program and tight BP control improve BP outcomes at 7-10 days postpartum compared with clinician-directed management and standard targets. Methods: Postpartum patients with chronic or gestational hypertension, preeclampsia/eclampsia, or HELLP (hemolysis, elevated liver enzymes, low platelets) syndrome were randomized simultaneously to two interventions (four arms total): (1a) comprehensive management with remote BP monitoring and algorithm-based treatment, (1b) clinician-directed management at the primary obstetric provider's discretion, and (2a) tight (<140/90 mmHg) versus (2b) standard (<150/100 mmHg) BP control. Outcomes were measured at 7-10 days postpartum; the primary outcome was in-office BP evaluation and secondary outcomes included BP ascertainment (remote or in-person), BP change from baseline, antihypertensive medication initiation, any BP ≥140/90 mmHg or ≥160/110 mmHg, and all-cause emergency department visits or hospital readmissions. Results: From May 9, 2023 to August 1, 2024, 334 of 660 eligible participants were randomized. There was no difference for the primary outcome of in-person BP visit attendance between the comprehensive and clinician-directed management interventions (62.5% [ Conclusion: A comprehensive postpartum BP management program with coaching and remote monitoring did not improve in-person BP visit attendance at 7-10 days postpartum but did increase odds of patients reporting any BP to a clinician. Findings from the secondary outcomes suggest that a tight BP target combined with the comprehensive BP management program reduced systolic BP and increased the odds of initiating new antihypertensives by 10 days postpartum.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.